This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Insmed Incorporated, Transave Limited. Active years: 2004-2015.
Location History:
- Belle Meade, NJ (US) (2004)
- Belle Mead, NJ (US) (2015)
Company Filing History:
Years Active: 2004-2015
Title: The Innovative Contributions of Jin K Lee
Introduction
Jin K Lee is a notable inventor based in Belle Mead, NJ (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of lipid-complexed platinum compounds. With a total of 3 patents, his work has the potential to impact cancer treatment methodologies.
Latest Patents
One of Jin K Lee's latest patents focuses on platinum aggregates and the process for producing them. This invention introduces a new form of lipid-complexed active platinum compound, which allows for higher concentrations of platinum in the composition. For instance, the concentration of cisplatin can exceed 1.2 mg/mL at room temperature, compared to 1 mg/mL in traditional aqueous solutions. The invention also details a composition that includes a lipid-complexed active platinum compound with a lipid to drug (L/D) ratio of less than 1 by weight. Additionally, the patent discusses the potential for these formulations to be used in pharmaceutical applications for inhalation or injection, providing new avenues for cancer treatment.
Career Highlights
Throughout his career, Jin K Lee has worked with several prominent companies, including Insmed Incorporated and Transave Limited. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.
Collaborations
Jin K Lee has collaborated with notable professionals in his field, including Frank G Pilkiewicz and Lawrence T Boni. These collaborations have likely enriched his research and development efforts, leading to advancements in his patented technologies.
Conclusion
Jin K Lee's innovative work in lipid-complexed platinum compounds showcases his commitment to improving cancer treatment options. His patents reflect a deep understanding of pharmaceutical formulations and their potential applications in medicine.